Jan 14, 2026 02:34PM Cantor Fitzgerald on TG Therapeutics (TGTX): 'Stock is at a very attractive valuation right now'

Jan 13, 2026 04:25PM TG Therapeutics reports $616M 2025 revenue, targets $875-900M for 2026

Nov 3, 2025 07:04AM TG Therapeutics (TGTX) Tops Q3 EPS by $2.21, Beats on Revenue; Offers Guidance

Oct 6, 2025 06:39AM H.C. Wainwright Starts TG Therapeutics (TGTX) at Buy

Sep 24, 2025 09:10AM TG Therapeutics reports six-year BRIUMVI data at ECTRIMS conference

Aug 4, 2025 01:41PM BofA Securities Reiterates Underperform Rating on TG Therapeutics (TGTX)

Aug 4, 2025 07:01AM TG Therapeutics (TGTX) Misses Q2 EPS by 2c, provides guidance

Jul 10, 2025 06:30AM Goldman Sachs Resumes TG Therapeutics (TGTX) at Neutral

Jul 2, 2025 02:32PM TG Therapeutics (TGTX) call put ratio 1 call to 1.5 puts with a focus on July 40 calls as share price up 1.3%

May 30, 2025 07:30AM TG Therapeutics (TGTX) Announces Data Presentations for BRIUMVI

May 5, 2025 04:08PM TG Therapeutics (TGTX) call put ratio 3 calls to 1 put with a focus on January 60 calls as share price down 13%

May 5, 2025 02:45PM Jefferies Reiterates Buy Rating on TG Therapeutics (TGTX)

May 5, 2025 07:03AM TG Therapeutics (TGTX) Misses Q1 EPS by 13c, provides guidance

Apr 10, 2025 07:30AM TG Therapeutics (TGTX) Announces Data Presentations for BRIUMVI

Apr 8, 2025 07:32AM TG Therapeutics (TGTX) Announces Data Presentations for BRIUMVI

Apr 7, 2025 07:32AM TG Therapeutics (TGTX) Announces Two Publications Highlighting BRIUMVI in Medical Journals

Apr 2, 2025 11:51AM Genentech Phase III Ocrevus High Dose Study in People With Relapsing Multiple Sclerosis Did Not Meet Primary Endpoint

Apr 2, 2025 11:49AM TG Therapeutics (TGTX) Shares Gain 8% After Roche Study

Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma

Mar 4, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on TG Therapeutics (TGTX)

Mar 3, 2025 03:34PM TG Therapeutics (TGTX) call put ratio 2.5 calls to 1 put with a focus on March calls as share price up 15%

Mar 3, 2025 01:07PM Cantor Fitzgerald Reiterates Overweight Rating on TG Therapeutics (TGTX)

Mar 3, 2025 07:06AM TG Therapeutics (TGTX) Tops Q4 EPS by 7c, provides outlook

Feb 27, 2025 07:32AM TG Therapeutics (TGTX) Announces Presentation of Data for BRIUMVI in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

Jan 15, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on TG Therapeutics (TGTX)

Jan 14, 2025 07:04AM TG Therapeutics (TGTX) Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development Milestones

Nov 5, 2024 06:42AM TG Therapeutics (TGTX) PT Raised to $55 at H.C. Wainwright

Nov 4, 2024 07:01AM TG Therapeutics (TGTX) Reports In-Line Q3 EPS, provides product guidance

Oct 29, 2024 05:35AM TD Cowen Starts TG Therapeutics (TGTX) at Buy

Sep 19, 2024 06:45AM H.C. Wainwright Reiterates Buy Rating on TG Therapeutics (TGTX)

Sep 18, 2024 07:15AM TG Therapeutics (TGTX): New BRIUMVI Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis

Sep 18, 2024 07:02AM TG Therapeutics (TGTX) Reports New BRIUMVI Data Showing 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment

Sep 6, 2024 06:28PM Zurn Elkay Water, Clear Secure, TG Therapeutics, others to join S&P SmallCap 600

Aug 7, 2024 06:17AM TG Therapeutics (TGTX) PT Raised to $30 at JPMorgan

Aug 6, 2024 07:43AM TG Therapeutics (TGTX) Tops Q2 EPS by 9c